



AT THE LIMITS OF VIABILITY:
A CLINICAL AND ETHICAL ISSUE
NA GRANICAMA VIABILNOSTI: KLINI^KI I ETI^KI PRIJEPOR
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SUMMARY. Fetal/neonatal viability, the survival rate and »intact« survival rate of very low gestational age fetuses resp.
of very low and extremely low birth weight newborns are presented. The mode of delivery i.e. the cesarean section in
maternal and in fetal/neonatal indications, in which the fetus cannot give an informed consent is discussed.
Pregled
Klju~ne rije~i: fetus, viabilnost, zastoj rasta, djeca vrlo niske porodne te`ine
SA@ETAK. Prikazani su fetalna i neonatalna odr`ivost, pre`ivljavanje i »neo{te}eno« pre`ivljavanje u fetusa vrlo male
gestacijske dobi odnosno u novoro|en~adi vrlo niske i izrazito niske porodne te`ine. Razmotreni su na~in ra|anja, tj.
carski rez kod maternalnih i fetalnih indikacija, u kojima fetus ne mo`e dati obavijesni pristanak.
Fetal viability has been defined as »the ability of the
fetus to survive ex utero with full technological support
through the neonatal period and into the second year of
life, during or near the end of which independent moral
status comes into existence«.1 Based on available clini-
cal results the same authors suggest that viability should
be considered at a gestational age of 24 weeks or more.2
However, it has also been pointed out that the term
»limit of viability« should be removed from our vocabu-
lary as it is clinically and ethically simplistic.3 In fact,
the outcome is not dependent only on gestational age
and/or birthweight but also on other possible fetal com-
plications. Moreover, the characteristics of »full techno-
logical support« to the newborn can significantly differ
between countries as well as centers within a country. It
should also be kept in mind that varying attitudes toward
neonatal intensive care greatly influence the survival
rate at two years of age, and the prevalence of disabling
cerebral palsy among survivors.4 ln fact, when more ag-
gressive management was applied, the survival rate and
the prevalence among survivors was higher as compared
to more conservative treatments. This observation intro-
duces the concept of »intact survival«, instead of the
crude figure of the survival rate alone. Both neona-
tologists and obstetricians, when faced with patients at
the limits of viability (mainly because of large pre-
maturity), they must take into consideration the clinical
and the ethical aspects of this issue.
However, when making decisions at the limits of via-
bility, obstetricians can be faced with far more complex
challenges in comparison with neonatologists. The neo-
natologist is required to provide the best possible care to
the critically ill newborn, but can consider the choice be-
tween intensive or compassionate care, in agreement
with the parents. In contrast, the obstetrician, being the
doctor of both the mother and the fetus, has to cope with
a very complex situation if a cesarean section (CS) is in-
dicated. If the indication for CS is maternal (placenta
praevia, abruptio placentae, eclampsia, etc.), the deci-
sion is straight forward to save the mother’s life. The
problem arises if the CS is required for fetal compromise
like hypoxia in a IUGR fetus, when the only efficient
management is delivery of the fetus to remove it from
the adverse maternal milieu.
In simple terms, this means performing a surgical pro-
cedure on the mother (the first patient) to presume a ben-
efit for the fetus (the second patient). Following the
principles of beneficence for the fetus and respecting its
autonomy, it is clear that the second patient (the fetus)
cannot be asked to give informed consent for the treat-
ment. As a consequence, exhaustive counseling in terms
of survival and intact survival probability based on the
best available evidence should be given to the parents,
particularly the mother. This is a difficult situation, as
clinical randomized trials comparing different manage-
ments for this particular condition are lacking.
There are many factors influencing early and late out-
come which should be taken into consideration, among
which gestational age and birth weight are the most im-
portant.
Gestational age
The concept of viability dependent on gestational age
at birth has changed in the last twenty years due to im-
provements in perinatal care. In 1984 Milligan et al.5
have observed a survival rate more than 50% at 25
weeks and above, and have indicated that intervention
for fetal indications was justified. One year later in 1985
Kitchen et al.6 reported a survival rate of 20% at 25
weeks, and in 1986 Yu et al.7 published a survival rate of
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25% at the same gestational age. In a short period of
time (three years) conflicting results concerning the sur-
vival of premature infants at lower limits of viability
have been presented by three major research centers.
About 15 years later the situation is not any clearer. In
1999 Bottoms et al.8 have reported the neonatal mortal-
ity rate and the intact survival rate in a large study. The
neonatal mortality rate has declined to 20.9%. Unfortu-
nately, despite the fact that survival rate increased sig-
nificantly (up to 80%), the »intact« survival rate re-
mained at only 35.8%. Similar results were reported in
2001 in the study by Chan et al.,9 who found that at 25
weeks survival rate was 76%, but only 32% of the survi-
vors were without major morbidity.
Looking at lower gestational ages, the outcome con-
sidering survival and intact survival rate were even
poorer. In 1999 it was reported by Hussain10 that there
are not survivors beyond 22 weeks and 3 days, with
unfavorable outcome (death or major disabilities) at
23 and 24 weeks occurring in more than 85% of new-
borns. Similar results were found in the year 2000 by
EL-Metwally et al.11 who considered only survival with-
out morbidity. The survival rate at 22, 23, 24 and 25
weeks were 4,6%, 46%, 59% and 82% respectively.
Such information which does not take morbidity among
survivors into account could be one of the reasons for
gynecologists to perform active management. Unfortu-
nately, in the recent study12 it has been shown that the
willingness to perform cesarean section at 23 weeks has
increased from 15,9% in 1995 to 28,2% in 2000, which
was not associated with the better neonatal outcome.
Moreover, it has also been recently reported that aggres-
sive obstetrical and neonatal management between 23
and 26 weeks was not associated with a better survival
rate, and that acute and chronic morbidity among survi-
vors did not change substantially.13
Birth weight
According to the birth weight (BW) newborns at the
lower limits are classified as low birth weight if BW is
less than 2500 g (LBW), very low birth weight if BW is
less than 1500 g (VLBW) and extremely low birth
weight, when BW is less than 1000 g (ELBW). From the
practical point of view it is easy to evaluate outcome ac-
cording to the BW, although its clinical significance is
limited. Low birth weight neonatal population is not ho-
mogeneous in terms of their gestational age because it
includes preterm and growth restricted newborns. More-
over, the papers reporting the management and outcome
of VLBW and ELBW are rarely taking into the consid-
eration infant gestational age, which means that criteria
for defining »viability« only on the estimation of birth
weight are not appropriate.
Fetal compromise
It has been shown that fetal compromise adversely af-
fects the outcome at the limits of viability.14 ln the group
of 142 babies born between 23 and 25 weeks, 43 have
presented at least with one sign of fetal compromise like
major congenital anomaly, congenital sepsis, chronic
intrauterine infection, intrauterine drug exposure, con-
genital anemia, severe IUGR, fetal acidemia, cardio-
respiratory and neurologic depression in the delivery
room. The majority of these conditions are detectable
before birth. Therefore an accurate evaluation of fetal
conditions is mandatory before making the decision
considering the way of conservative or more aggressive
treatment.
Mode of delivery
As it was mentioned before, if the indication for CS is
maternal, than the obstetrician has an obligation to per-
form the treatment in the best interest of the mother's
health. The choice is more difficult when the possible
indication for CS is fetal. The most common situations
in which CS can be considered as an option for improv-
ing neonatal outcome at low gestational age are fetal
hypoxemia and breech or other malpresentation. These
indications should be analyzed and discussed separa-
tely. Fetal hypoxemia is present in 30 to 35% of IUGR
fetuses, particularly in ELBW fetuses. The only avail-
able treatment delivery and therefore very often indica-
tions for CS should be discussed. Among factors which
should be taken into consideration the most important
are gestational age, estimated birth weight, gender, ab-
sence of fetal malformations and the characteristics of
the feto-placental hemodynamics.15 ln fact when absent
or reversed end-diastolic flow (ARED) are observed it is
necessary to distinguish between end-diastolic flow area
(EDFA) and reverse flow (RF). In the last condition the
prevalence of severe handicaps among survivors is more
than 35%.16
In the case of breech presentation and prematurity, the
most important issue of making the decision to perform
the CS is to reduce or to avoid birth trauma, which can
possibly cause neurological damage or impairment. Ac-
cording to the available data this goal could not be
achieved by delivering the ELBW at risk by CS.17–19 In
fact it has been shown that CS in breech presentation of
VLBW and ELBW does not improve the outcome if
looking at the intact survival. It should be remembered
that in tiny premature infants the majority of the causes
of cerebral palsy are the consequence of prematurity by
itself.
Conclusions
The concept of fetal viability is unclear and strongly
dependent on ethical, moral and religious personal be-
lief. Therefore it is very difficult or almost impossible to
make universal guidelines for the management of ex-
tremely premature fetuses and infants. The bulletin of
American College of Obstetricians and Gynecologists
»Perinatal Care at the Threshold of Viability« edited in
September 200220 offers Recommendations of Level A
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which are rather imprecise, mainly focused on the im-
portance of the information to the family. Also the pres-
ent scenario is not encouraging as it has been shown that
in VLBW the rate of mortality, pneumothorax, intra-
ventricular hemorrhage (IVH) and severe IVH has de-
clined till 1995 but from 1995 to 1999 there were no sig-
nificant changes in the incidence of IVH, while the inci-
dence of pneumothorax increased.21 Therefore the abil-
ity for appropriate counseling of the parents concerning
the treatment of infants at the limits of viability did not
change in the last few years, and it is dependent on the
local mortality and morbidity statistics for those tiny in-
fants. Obstetricians should always remember that the
parental perception of »good short or long term out-
come« significantly differ compared to the doctors. The-
refore the obstetricians should make any effort to under-
stand the parents and to practice what they preach.
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